CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −4,592 | $3.95 | $18K | 223,210 |
| 2022-02-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −4,852 | $10.95 | $53K | 227,802 |
| 2021-12-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award | +37,800 | 232,654 | ||
| 2021-12-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award · Stock Option | +67,150 | 67,150 | ||
| 2021-11-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −6,061 | $13.16 | $80K | 194,854 |
| 2021-08-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −6,192 | $13.83 | $86K | 200,915 |
| 2021-05-17 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −6,085 | $18.30 | $111K | 207,107 |
| 2021-02-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −15,358 | $22.37 | $344K | 213,192 |
| 2020-12-18 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award | +28,550 | 228,550 | ||
| 2020-12-18 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award · Stock Option | +51,000 | 51,000 | ||
| 2019-12-02 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award | +200,000 | 200,000 | ||
| 2019-12-02 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award · Stock Option | +200,000 | 200,000 |
Page 1 of 1 · 12 trades